Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Erwin Deutsch is active.

Publication


Featured researches published by Erwin Deutsch.


Fibrinolysis and Proteolysis | 1987

Factor XII activity and antigen concentrations in patients suffering from recurrent thrombosis

Christine Mannhalter; M. Fischer; P. Hopmeier; Erwin Deutsch

Abstract A group of 107 patients with recurrent venous thrombosis was tested for factor XII coagulant activity and antigen. Among these patients eleven were identified with Hageman factor (FXII) levels below our normal mean value minus two standard deviations (SD). A control group of 55 individuals without thrombosic problems was studied simultaneously. The factor XII levels of these persons were all within the normal range (normal mean ± 2 SD). The I I patients with reduced levels of factor XII belonged to seven families, 5 with positive history of thrombosis. On average, they experienced their first thrombosis at a younger age than the other patients, which supports the theory of a hereditary defect. Thus, reduced levels of factor XII should be considered as a risk factor in the development of thrombosis.


American Journal of Cardiology | 1960

Pyrogens as thrombolytic agents: Clinical and experimental studies☆

Erwin Deutsch; Peter Elsner

Abstract Four effects of intravenously injected purified bacterial pyrogens are discussed: 1. 1. The induction of a leukopenia within the first hour after injection of the pyrogen. This is followed by a leukocytosis lasting for many hours. 2. 2. The induction of fibrinolysis beginning about sixty minutes after the injection and lasting for about ninety minutes. It is caused by the appearance of a great amount of a stable type activator in addition to a small amount of a labile type activator. In vitro experiments and some clinical observations suggest that the leukocytes may be a source of the stable type activator which may be liberated from the leukocytes (and possibly other cells) at the time of development of leukopenia. The activator induces the formation of free plasmin. We found in only a few cases, that another mechanism was responsible for the activation of fibrinolysis, a lysokinase, which induces the formation of a labile type activator. 3. 3. Effects on blood coagulation are not caused by the pyrogen itself. The most obvious effect is the development of a hypercoagulability, which could be demonstrated to be a general side effect of the action of proteolytic enzymes in low concentrations. The same effect, but less marked, may be observed after administration of nicotinic acid, small amounts of streptokinase, and trypsin. When the proteolytic activity is fully developed, a digestion of factors v and viii and to a smaller degree of prothrombin and factor vii is observed. Splitting products of fibrinogen cause a distinct antithrombin activity. 4. 4. The body temperature is elevated. A period of about ninety minutes after the injection is necessary for the formation of the intrinsic pyrogen which finally causes the rise in temperature. Leukocytes are apparently involved in this transformation.


Acta Haematologica | 1982

Systemic Candidiasis Complicating Bone Marrow Transplantation in Aplastic Anemia

Wolfgang Hinterberger; Leo Fridrich; Wolfgang Graninger; Gunter Kleinberger; Klaus Lechner; E. Neumann; Josef D. Schwarzmeier; Taddäus Radaskiewicz; Erwin Deutsch

A 17-year-old male patient with aplastic anemia underwent bone marrow transplantation and succumbed 4 days after marrow infusion from sudden myocardial failure. Fever of unknown origin (FUO) had accompanied the patients course from admission until death. The cause of death was fungus myocarditis, which had escaped detection in vivo, in spite of a daily culture program for bacteria and fungi, and a close monitoring of the patients circulation and ventricular performance. Commonly applied diagnostic criteria for systemic mycosis, such as topical colonization, malfunction of invaded organs and positive fungus cultures failed to provide a timely diagnosis. With regard to the problems in diagnosing systemic mycosis, the potential stem cell toxicity of antifungal drugs and the need for immunosuppressive therapy prior to marrow infusion, we strongly recommend not to start the transplantation procedure unless FUO has been treated successfully.


Archive | 1985

Neopterin Levels in Serum After Bone Marrow Transplantation are Possibly Helpful to Estimate the Activity of Graft-Versus-Host-Disease

Peter Kalhs; M. Fischer; Robert Dudczak; Wolfgang Hinterberger; Beatrix Volc-Platzer; Klaus Lechner; H. Frischauf; Ilse Schwarzinger; Erwin Deutsch

Neopterin, (Npt,6-1’,2’,3’-D-erythrotrihydroxy)propy-pteridin) is formed from Guanosine-Triphosphate during the biosynthesis of Tetra-hydrobiopterine, a co-factor of aromatic hydroxylation. The biological function of Npt is not yet known.It has been shown, that stimulation of T-lymphocytes in viral infections and malignant disorders may cause elevation of Npt levels in serum and urine (1,2,3,4). The aim of this study was to evaluate the usefulness of regular radioimmunological determinations of serum-Npt levels in human bone marrow graft recipients suffering from GVH-D reactions.


The Journal of Clinical Endocrinology and Metabolism | 1986

Effect of Thyroid Hormones on Plasma Protein Concentrations in Man

Wolfgang Graninger; Klaus R. Pirich; Wolfgang Speiser; Erwin Deutsch; Werner Waldhäusl


The Journal of Clinical Endocrinology and Metabolism | 1977

The Diabetogenic Action of Somatostatin in Healthy Subjects and in Maturity Onset Diabetics

Werner Waldhäusl; Paul Bratusch-Marrain; Robert Dudczak; Erwin Deutsch


Scandinavian Journal of Haematology | 2009

Deficiency of fibrinogen and factor VII following treatment of severe aplastic anaemia with anti-thymocyte globulin and high-dose methylprednisolone.

M. Fischer; Klaus Lechner; Wolfgang Hinterberger; H. Niessner; Ingrid Pabinger; Robert Dudczak; E. Neumann; C. Korninger; Erwin Deutsch


Scandinavian Journal of Haematology | 2009

Treatment of severe chronic idiopathic thrombocytopenic purpura in adults with high-dose intravenous gammaglobulin

C. Korninger; Simon Panzer; Wolfgang Graninger; E. Neumann; H. Niessner; Klaus Lechner; Erwin Deutsch


Pathophysiology of Haemostasis and Thrombosis | 1984

CRM+ Severe Fletcher Factor Deficiency Associated with Graves’ Disease

Kyrle Pa; H. Niessner; Erwin Deutsch; Klaus Lechner; C. Korninger; Christine Mannhalter


Clinical Nutrition | 1982

ESPEN 1982 4th Congress of the European Society of Parenteral and Enteral Nutrition Vienna, Austria, September 26–29, 1982

Erwin Deutsch; Gunter Kleinberger

Collaboration


Dive into the Erwin Deutsch's collaboration.

Top Co-Authors

Avatar

Klaus Lechner

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Wolfgang Graninger

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert Dudczak

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Christine Mannhalter

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge